These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33582693)

  • 21. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
    Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
    Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
    Ozturk O; Doganay L; Colak Y; Yilmaz Enc F; Ulasoglu C; Ozdil K; Tuncer I
    Arab J Gastroenterol; 2017 Jun; 18(2):62-67. PubMed ID: 28601610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection.
    Alsohaibani F; Al Ashgar H; Al Kahtani K; Kagevi I; Peedikayil M; Alfadda A; Khan M
    Saudi J Gastroenterol; 2015; 21(4):220-5. PubMed ID: 26228365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
    Tong JL; Ran ZH; Shen J; Xiao SD
    J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
    Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
    Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study.
    Phiphatpatthamaamphan K; Vilaichone RK; Siramolpiwat S; Tangaroonsanti A; Chonprasertsuk S; Bhanthumkomol P; Pornthisarn B; Mahachai V
    Asian Pac J Cancer Prev; 2016; 17(4):1903-7. PubMed ID: 27221874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates.
    Rakici H; Akdoğan RA; Bedir R; Copur A; Yilmaz A
    J Dig Dis; 2014 Sep; 15(9):508-13. PubMed ID: 24980811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
    Zullo A; Scaccianoce G; De Francesco V; Ruggiero V; D'Ambrosio P; Castorani L; Bonfrate L; Vannella L; Hassan C; Portincasa P
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):647-50. PubMed ID: 23747131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial.
    Jha SK; Mishra MK; Saharawat K; Jha P; Purkayastha S; Ranjan R
    Indian J Gastroenterol; 2019 Aug; 38(4):325-331. PubMed ID: 31520370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya.
    Laving A; Kamenwa R; Sayed S; Kimang'a AN; Revathi G
    S Afr Med J; 2013 Oct; 103(12):921-4. PubMed ID: 24300630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.
    Kim SY; Lee SW; Hyun JJ; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Choi JH
    J Clin Gastroenterol; 2013 Jan; 47(1):21-4. PubMed ID: 22647826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.
    Haider RB; Brennan DE; Omorogbe J; Holleran G; Hall B; O'Morain C; Breslin N; O'Connor HJ; Smith SM; McNamara D
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1265-9. PubMed ID: 26287955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential therapy for Helicobacter pylori eradication.
    Yakut M; Çinar K; Seven G; Bahar K; Özden A
    Turk J Gastroenterol; 2010 Sep; 21(3):206-11. PubMed ID: 20931421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication].
    Kim SY; Park DK; Kwon KA; Kim KO; Kim YJ; Chung JW
    Korean J Gastroenterol; 2014 Nov; 64(5):260-7. PubMed ID: 25420735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.
    Lee JW; Kim N; Kim JM; Nam RH; Kim JY; Lee JY; Lee DH; Jung HC
    Scand J Gastroenterol; 2014 Aug; 49(8):917-24. PubMed ID: 24988873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.